MiR-320a-3p/ELF3 axis regulates cell metastasis and invasion in non-small cell lung cancer via PI3K/Akt pathway

被引:64
|
作者
Zhao, Wen [2 ]
Sun, Qiang [4 ]
Yu, Zepeng [1 ]
Mao, Shuai [5 ]
Jin, Yingkang [2 ]
Li, Jiajun [1 ]
Jiang, Zhiyi [1 ]
Zhang, Yongqiang [1 ]
Chen, Mian [1 ]
Chen, Peiran [1 ]
Chen, Dongdong [1 ]
Xu, Hailin [1 ]
Ding, Shangwei [3 ]
Yu, Zhiqi [1 ]
机构
[1] Guangzhou Med Univ, Affiliated Hosp 2, Dept Resp Med, Guangzhou 510260, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Affiliated Hosp 1, Dept Resp Med, Guangzhou 510120, Guangdong, Peoples R China
[3] Southern Med Univ, Dongguan Peoples Hosp, Dept Ultrasonog, Dongguan 523059, Guangdong, Peoples R China
[4] Zhongshan Sch Med, Sun Yat Sen Univ Michigan State Univ Joint Ctr Ve, Guangzhou 510080, Guangdong, Peoples R China
[5] Guangdong Prov Hosp Chinese Med, Dept Crit Care Med, Guangzhou 510120, Guangdong, Peoples R China
关键词
miR-320a-3p; ELF3; PI3K/Akt; NSCLC; ELF3; MESSENGER-RNA; TRANSCRIPTION FACTOR; LIVER METASTASIS; ESE-1;
D O I
10.1016/j.gene.2018.05.100
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
MicroRNAs (miRNAs) play important roles in tumorigenesis and tumor progression. In this study, we investigated the role of miR-320a-3p in non-small cell lung cancer (NSCLC). Expressions of miR-320a-3p were firstly determined in 80 NSCLC patients' cancer tissues and adjacent normal lung tissues by qRT-PCR. Then MTT assay, cell migration and invasion assays were performed in vitro. Potential binding sites on target gene of miR320a-3p were predicted and luciferase reporter assay was used to identify the potential binding sites. Tumorigenesis assay were performed in nude mice by injecting A549 cells which stably express miR-320a-3p. Results indicated that high expression of miR-320a-3p suppresses cell proliferation, migration and invasion through the inactivation of PI3K/Akt signaling pathway in NSCLC cells. Smaller tumor size and lighter weight were also found in nude mice which had miR-320a-3p higher expressed. Furthermore, data from luciferase reporter assay proved the direct binding of miR-320a-3p on the 3'UTR region of ELF3 mRNA, this could further decrease ELF3 expression transcriptionally. We provided evidence that miR-320a-3p might work as a tumor suppressor in NSCLC both in vivo and in vitro.
引用
收藏
页码:31 / 37
页数:7
相关论文
共 50 条
  • [1] miR-320/ELF3 axis inhibits the progression of breast cancer via the PI3K/AKT pathway
    Zhang, Zhiqiang
    Zhang, Jinku
    Li, Jinmei
    Geng, Huijuan
    Zhou, Bingjuan
    Zhang, Bingxin
    Chen, Hong
    [J]. ONCOLOGY LETTERS, 2020, 19 (04) : 3239 - 3248
  • [2] Overexpression of ELF3 facilitates cell growth and metastasis through PI3K/Akt and ERK signaling pathways in non-small cell lung cancer
    Wang, Hao
    Yu, Zhiqi
    Huo, Shaofen
    Chen, Zheng
    Ou, Zhiling
    Mai, Jiajie
    Ding, Shangwei
    Zhang, Jinshan
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2018, 94 : 98 - 106
  • [3] LncRNA WTI-AS/miR-494-3p Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway in Non-Small Cell Lung Cancer
    Wu, Chaohui
    Yang, Jiansheng
    Li, Rongbin
    Lin, Xianbin
    Wu, Jiayun
    Wu, Jingyang
    [J]. ONCOTARGETS AND THERAPY, 2021, 14 : 891 - 904
  • [4] MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT
    Zhu, Qing
    Zhang, Yixuan
    Li, Mo
    Zhang, Ying
    Zhang, Huan
    Chen, Jiayi
    Liu, Zhaoyang
    Yuan, Peng
    Yang, Zhaogang
    Wang, Xiaobing
    [J]. BIOMARKER RESEARCH, 2023, 11 (01)
  • [5] The miR-1224-5p/ELF3 Axis Regulates Malignant Behaviors of Pancreatic Cancer via PI3K/AKT/Notch Signaling Pathways
    Kong, Lingming
    Liu, Peng
    Zheng, Mingjun
    Wang, Zhongpeng
    Gao, Yang
    Liang, Keke
    Wang, Huaitao
    Tan, Xiaodong
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 3449 - 3466
  • [6] RETRACTION: LncRNA WT1-AS/mir-494-3P Regulates Cell Proliferation, Apoptosis, Migration and Invasion via PTEN/PI3K/AKT Signaling Pathway In Non-Small Cell Lung Cancer
    Wu, C.
    Yang, J.
    Li, R.
    Lin, X.
    Wu, J.
    [J]. ONCOTARGETS AND THERAPY, 2024, 17 : 739 - 739
  • [7] Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer (NSCLC)
    Tan, Aaron C.
    [J]. THORACIC CANCER, 2020, 11 (03) : 511 - 518
  • [8] MiR-124-3p impedes the metastasis of non-small cell lung cancer via extracellular exosome transport and intracellular PI3K/AKT signaling
    Qing Zhu
    Yixuan Zhang
    Mo Li
    Ying Zhang
    Huan Zhang
    Jiayi Chen
    Zhaoyang Liu
    Peng Yuan
    Zhaogang Yang
    Xiaobing Wang
    [J]. Biomarker Research, 11
  • [9] Targeting the PI3K/Akt/mTOR pathway in non-small cell lung cancer spheroids
    Vella, Nathan
    Estevao, Diogo
    Cruz, Tania
    Oliveira, Maria Jose
    Fenech, Anthony George
    Magri, Vanessa Petroni
    [J]. CANCER RESEARCH, 2024, 84 (07)
  • [10] The lncRNA NORAD/miR-520a-3p Facilitates Malignancy in Non-Small Cell Lung Cancer via PI3k/Akt/mTOR Signaling Pathway
    Wan, Yunyan
    Yao, Zhouhong
    Chen, Weijuan
    Li, Dezhi
    [J]. ONCOTARGETS AND THERAPY, 2020, 13 : 1533 - 1544